A synergistic peptide blend designed for advanced research applications focused on growth hormone signaling and recovery pathways. This combination pairs CJC-1295 (no DAC), a growth hormone–releasing hormone (GHRH) analog, with Ipamorelin, a selective growth hormone secretagogue, to support pulsatile GH release in research models.
CJC-1295 (no DAC) works by stimulating the natural release of growth hormone, while Ipamorelin complements this action by mimicking ghrelin pathways without significantly impacting cortisol or prolactin levels in studied environments. Together, they are commonly explored for their potential roles in recovery, tissue support, and metabolic function.
Product Details:
Total Content: 20mg peptide blend
Combination: CJC-1295 (no DAC) + Ipamorelin
Format: Designed for use with a preloaded, easy-to-use delivery system
Application: Research use only
Key Features:
Easy to use, hassle-free, preloaded and ready to use
